This is a heavily interactive web application, and JavaScript is required. Simple HTML interfaces are possible, but that is not what this is.
Post
NephroTopo
nephrotopo.bsky.social
did:plc:lst5cqxilyfsjk74gp7uek2v
💥 GEM : évaluer le risque de progression
#nephrotopoÂ
🧬 Rémission immuno avant clinique
📆 Ac anti-PLA2R : suivi tous les 3–6 mois
📉 ↓ = réponse
📈 ↑ = échec + mauvais pronostic
💉 >150 RU/mL → rituximab
📚https://www.filiereorkid.com/wp-content/uploads/2022/11/PNDS-GEM_Texte_15112022.pdf
2025-06-15T10:01:43.344Z